Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
CHIPOR trial: what clinicians have said so far
Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment
- NCT01376752 ↗
- Active, not recruiting
- UNICANCER
- Standard size, estimated: 151–300 verified statements
We haven't built an HCP commentary report on CHIPOR (recurrent ovarian cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on CHIPOR so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 12 posts on X | |
| 4 YouTube videos | |
| 3 podcast episodes |
The trial
ClinicalTrials.gov- Official title
- A Phase III Randomized Study Evaluating Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the Treatment of Relapse Ovarian Cancer
- Phase
- Phase 3
- Status
- Active, not recruiting
- Conditions
- Ovarian Epithelial Cancer Recurrent
- Interventions
- Maximal cytoreductive surgery; HIPEC
- Arms
- maximal cytoreductive surgery without HIPEC · Active comparator
- maximal cytoreductive surgery with HIPEC · Experimental
- Enrollment
- 415
- Primary outcomes
- overall survival
- Sponsor
- UNICANCER
- Start
- Apr 26, 2011
- Primary completion
- Jan 8, 2023
- Results posted
- No
- Registry record
- NCT01376752 · updated May 20, 2026
Publications
linked from the registry- Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN, Glehen O. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol. 2006 Mar;13(3):405-12. doi: 10.1245/ASO.2006.05.041. Epub 2006 Jan 30. PubMed 16485159
- Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA; Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006 Jan 5;354(1):34-43. doi: 10.1056/NEJMoa052985. PubMed 16394300
- Classe JM, Meeus P, Hudry D, Wernert R, Quenet F, Marchal F, Houvenaeghel G, Bats AS, Lecuru F, Ferron G, Brigand C, Berton D, Gladieff L, Joly F, Ray-Coquard I, Durand-Fontanier S, Liberale G, Pocard M, Georgeac C, Gouy S, Guilloit JM, Guyon F, Costan C, Rousselet JM, de Guerke L, Bakrin N, Brument E, Martin E, Asselain B, Campion L, Glehen O; UNICANCER/CHIPOR Investigators. Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial. Lancet Oncol. 2024 Dec;25(12):1551-1562. doi: 10.1016/S1470-2045(24)00531-X. Epub 2024 Nov 14. PubMed 39549720